• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Repligen Corporation - Common Stock (NQ:RGEN)

    133.62 +3.03 (+2.32%)
    Streaming Delayed Price Updated: 11:44 AM EDT, Jun 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 136,377
    Open 133.71
    Bid (Size) 133.53 (200)
    Ask (Size) 133.75 (100)
    Prev. Close 130.59
    Today's Range 130.73 - 134.59
    52wk Range 100.99 - 175.77
    Shares Outstanding 55,679,964
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Out-of-Favor Stocks We Keep Off Our Radar
    Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co... 
    Via StockStory
    News headline image
    Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
    As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
    Via StockStory

    Performance

    YTD
    -18.7%
    -18.7%
    1 Month
    +29.9%
    +29.9%
    3 Month
    +16.1%
    +16.1%
    6 Month
    -16.8%
    -16.8%
    1 Year
    +6.0%
    +6.0%

    More News

    Read More
    News headline image
    Why Repligen (RGEN) Stock Is Trading Up Today
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    1 Growth Stock with Explosive Upside and 2 Facing Headwinds
    Via StockStory
    Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    3 Small-Cap Stocks We Steer Clear Of
    Via StockStory
    News headline image
    Repligen (RGEN) Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Earnings Regulatory Compliance
    News headline image
    Repligen (RGEN) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates
    Via StockStory
    Topics Earnings
    News headline image
    Repligen (RGEN) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Repligen (RGEN) Shares Are Plunging Today
    Via StockStory
    Topics Economy Regulatory Compliance
    News headline image
    Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid
    Via StockStory
    News headline image
    1 Cash-Producing Stock Worth Your Attention and 2 We Avoid
    Via StockStory
    News headline image
    RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy Government Stocks
    News headline image
    1 High-Flying Stock with Solid Fundamentals and 2 We Avoid
    Via StockStory
    News headline image
    1 Cash-Heavy Stock to Target This Week and 2 We Question
    Via StockStory
    News headline image
    A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
    Via StockStory
    News headline image
    2 Growth Stocks Set to Flourishand 1 We Turn Down
    Via StockStory
    News headline image
    3 Profitable Stocks We Keep Off Our Radar
    Via StockStory
    Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million ↗
    Via The Motley Fool
    News headline image
    AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Via StockStory

    Frequently Asked Questions

    Is Repligen Corporation - Common Stock publicly traded?
    Yes, Repligen Corporation - Common Stock is publicly traded.
    What exchange does Repligen Corporation - Common Stock trade on?
    Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Repligen Corporation - Common Stock?
    The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
    What is the current price of Repligen Corporation - Common Stock?
    The current price of Repligen Corporation - Common Stock is 133.62
    When was Repligen Corporation - Common Stock last traded?
    The last trade of Repligen Corporation - Common Stock was at 06/15/26 11:44 AM ET
    What is the market capitalization of Repligen Corporation - Common Stock?
    The market capitalization of Repligen Corporation - Common Stock is 7.44B
    How many shares of Repligen Corporation - Common Stock are outstanding?
    Repligen Corporation - Common Stock has 7B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.